ABCDE集束化治疗依从性与长期结局的关联:一项二次纵向分析
该研究为一项随机对照试验(MIND-USA,NCT01211522)的二次纵向分析,纳入2011至2017年间来自16家美国医疗中心的566例呼吸衰竭和/或休克成人重症患者,患者均接受每日ABCDE集束化治疗。中位比例集束化依从性为97%,提示总体高保真度。校正协变量后,更高的集束化依从性与12个月功能活动问卷评分更低(β=-9.6,CI=-19.6,-1.7,p=0.04)和12个月EuroQol-5D评分更高(β=0.5,CI=0.1,0.9,p=0.01)相关;与长期认知、心理健康或生存无关联。
要点
- 在16家美国医疗中心566例呼吸衰竭和/或休克成人中,中位ABCDE集束化依从性达97%,总体保真度高。
- 校正协变量后,更高集束化依从性与12个月功能活动问卷评分更低相关(β=-9.6,CI=-19.6,-1.7,p=0.04),提示工具性日常生活活动残疾更少。
- 更高集束化依从性与12个月EuroQol-5D评分更高相关(β=0.5,CI=0.1,0.9,p=0.01),提示健康相关生活质量更好。
- 更高集束化依从性与长期认知、心理健康或生存无关联,各域关联不一致。
- 作者认为,未来研究应评估整合集束化治疗与出院后干预以优化长期康复。
适用人群与场景
- 2011至2017年从16家美国医疗中心招募的成人呼吸衰竭和/或休克重症患者,均接受每日ABCDE集束化治疗。
- 566例参与者中418例存活至出院,304例完成3个月结局评估,251例完成12个月结局评估。
研究设计与关键结果
- 研究类型为随机对照试验(比较氟哌啶醇、齐拉西酮与安慰剂治疗危重症谵妄)的二次纵向分析,纳入566例成人呼吸衰竭和/或休克患者,来自16家美国医疗中心。
- 中位比例集束化依从性为97%,提示总体高保真度。
- 校正协变量后,更高比例集束化依从性与12个月功能活动问卷评分更低相关(β=-9.6,CI=-19.6,-1.7,p=0.04)。
- 更高集束化依从性与12个月EuroQol-5D评分更高相关(β=0.5,CI=0.1,0.9,p=0.01)。
- 更高集束化依从性与长期认知、心理健康或生存无关联。
证据类型、等级与局限
- 证据类型:随机对照试验的二次纵向分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,未来研究应评估整合集束化治疗与出院后干预以优化长期康复。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: There is limited information on the relationship between multidisciplinary bundle compliance and long-term outcomes. We explored the association between bundle compliance and outcomes at 3 and 12 months after hospital discharge.
METHODS: We conducted secondary analyses of a randomized controlled trial comparing haloperidol, ziprasidone, and placebo for delirium in patients with critical illness. From 2011 to 2017, adult patients with respiratory failure and/or shock were recruited from 16 US medical centers. Participants received a daily ABCDE bundle during their critical illness. We assessed cognition, disability, mental health, quality of life, and survival over 12 months of follow-up. We analyzed data using linear mixed effects regression and Cox proportional hazards models.
RESULTS: Among 566 participants, 418 survived to hospital discharge, 304 were assessed for 3-month outcomes, and 251 for 12-month outcomes. Median proportional bundle compliance was 97%, indicating high overall fidelity. After adjusting for covariates, greater proportional bundle compliance was associated with better functional independence and health-related quality of life, as evidenced by lower 12-month Functional Activity Questionnaire scores (β = - 9.6, CI = - 19.6, - 1.7, p = 0.04) and higher 12-month EuroQol-5D scores (β = 0.5, CI = 0.1, 0.9, p = 0.01). Greater bundle compliance was not associated with better long-term cognition, mental health, or survival.
CONCLUSION: In this multi-site cohort with high-fidelity bundle compliance, greater bundle compliance was associated with less disability in instrumental activities of daily living and better health-related quality of life at 12 months, though associations were inconsistent and absent across other domains. Future research should evaluate integrated bundle care with post-discharge interventions to optimize long-term recovery.
TRIAL REGISTRATION: The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA Study (MIND-USA), NCT01211522, https://clinicaltrials.gov/ct2/show/NCT01211522 .
参考来源
- Boehm LM, Mart MF, LaNoue M, et al. Association between ABCDE bundle compliance and long-term outcomes: a secondary longitudinal analysis. Intensive Care Med. 2026. PMID: 41739187. doi:10.1007/s00134-026-08346-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。